GRCE insider trades & Congress trades
Grace Therapeutics, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 22 open-market insider transactions in Grace Therapeutics, Inc. (GRCE) (22 purchases with code P and 0 sales with code S), the most recent on November 5, 2026.
In the last 90 days: 22 purchases by 2 insiders ($807K) and 0 sales by 0 ($0).
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Opaleye Management Inc. | – | Buy | 3,087 | $1.77 | $5K | – |
| Nov 4, 2026 | Opaleye Management Inc. | – | Buy | 5,027 | $1.80 | $9K | – |
| Nov 3, 2026 | Opaleye Management Inc. | – | Buy | 10,328 | $1.79 | $18K | – |
| Oct 26, 2026 | Opaleye Management Inc. | – | Buy | 66,411 | $1.77 | $117K | – |
| Oct 22, 2026 | Opaleye Management Inc. | – | Buy | 21,390 | $1.93 | $41K | – |
| Oct 19, 2026 | Opaleye Management Inc. | – | Buy | 4,256 | $1.88 | $8K | – |
| Oct 16, 2026 | Opaleye Management Inc. | – | Buy | 36,347 | $1.89 | $69K | – |
| Oct 15, 2026 | Opaleye Management Inc. | – | Buy | 23,485 | $1.95 | $46K | – |
| Oct 14, 2026 | Opaleye Management Inc. | – | Buy | 11,233 | $1.93 | $22K | – |
| Oct 12, 2026 | Opaleye Management Inc. | – | Buy | 7,215 | $2.02 | $15K | – |
| Oct 9, 2026 | Opaleye Management Inc. | – | Buy | 5,340 | $2.04 | $11K | – |
| Oct 8, 2026 | Opaleye Management Inc. | – | Buy | 2,077 | $2.02 | $4K | – |
| Oct 5, 2026 | Opaleye Management Inc. | – | Buy | 1,694 | $2.06 | $3K | – |
| Oct 2, 2026 | Opaleye Management Inc. | – | Buy | 20,000 | $2.07 | $41K | – |
| Oct 1, 2026 | Opaleye Management Inc. | – | Buy | 38,796 | $2.04 | $79K | – |
| Sep 29, 2026 | Opaleye Management Inc. | – | Buy | 7,849 | $2.09 | $16K | −0.0% |
| Sep 23, 2026 | Opaleye Management Inc. | – | Buy | 5,318 | $2.10 | $11K | – |
| Sep 21, 2026 | Opaleye Management Inc. | – | Buy | 9,771 | $2.10 | $21K | −0.0% |
| Sep 9, 2026 | Kohli Prashant | Chief Executive Officer | Buy | 100,000 | $2.14 | $214K | −0.1% |
| Sep 9, 2026 | Opaleye Management Inc. | – | Buy | 5,836 | $2.09 | $12K | −0.1% |
| Sep 8, 2026 | Opaleye Management Inc. | – | Buy | 9,393 | $2.10 | $20K | −0.1% |
| Aug 14, 2026 | Opaleye Management Inc. | – | Buy | 11,608 | $2.09 | $24K | −0.0% |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.